Check out the companies that made the biggest moves midday: Oracle — AI stocks fell 4% as investors remained concerned about AI-related valuations. These declines compounded weekly losses for Oracle and Nvidia. Bath & Body Works — The retailer fell 5%, joining a 24.8% plunge from Thursday, as analysts around Wall Street downgraded the stock. Morgan Stanley and Goldman Sachs were among the companies that downgraded Bath & Body Works a day after the company reported weaker-than-expected third-quarter results. QuidelOrtho — The diagnostic products maker rose 11% after CEO Brian Blazer disclosed a purchase of 23,500 shares. AZENTA — Shares rose more than 10% after the laboratory equipment company reported fourth-quarter earnings that beat analysts’ expectations. The company reported earnings per share, excluding certain items, of 21 cents on revenue of $159.2 million. Analysts polled by FactSet had expected profit of 19 cents on revenue of $156.2 million. Enviri — The waste management company rose nearly 29% after it agreed to sell its hazardous and non-hazardous waste division, Clean Energy, to rival Veolia for $3.04 billion. Enviri will also spin off its Harsco Environmental and Rail divisions as New Enviri. The deal is expected to close in mid-2026. Bitcoin stocks — Stocks tied to the world’s oldest cryptocurrency were in the red as Bitcoin plummeted to nearly $80,000 as investors fled risky assets. Digital asset mining companies American Bitcoin and Riot Platforms fell 8% and 2% in deference. Bitcoin Financial Strategy fell 3%. Galaxy Digital fell 5%. Elastic — The data analytics company fell 14% after reporting second-quarter results that showed cloud growth slowed. Elastic’s adjusted earnings and revenue exceeded Wall Street expectations. Veeva Systems — Veeva Systems fell 11% after the cloud solutions provider said it expects fewer top biopharmaceutical companies to choose its Vault CRM. Veeva reported third-quarter earnings of $2.04 per share, excluding one-time items, and revenue of $811.2 million. That compared to analysts’ consensus estimates of $1.95 and revenue of $792.8 million. Gap — The apparel retailer saw same-store sales surge more than 8% in the latest quarter, beating expectations with a 5% increase in same-store sales thanks to its viral “Better in Denim” campaign with Katseye. Excluding the pandemic, same-store sales growth was the largest since the holiday quarter of fiscal 2017. Ross Stores — The retailer reported better-than-expected sales of $5.6 billion compared to the analyst consensus estimate of $5.42 billion, pushing the stock up 4%. Ross also raised his earnings outlook for the fourth quarter, saying, “We expect tariff-related costs to be negligible.” Anaptis Bio — The biotech company fell 2% after drugmaker Tesaro said it would sue Anaptis Bio for allegedly violating a licensing agreement for its oncology drug Gemperi. —CNBC’s Michelle Fox Theobald and Yun Li contributed reporting.
